Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Chennai, India, 1990-1999 cases followed-up to 2001)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases	Male			Female			Number of cases by age group					Relative survival by age group
			5-year survival			5-year survival			Number of cases by age group					Relative survival by age group
			No.	Abs	Rel	No.	Abs	Rel	<45	45-54	55-64	65-74	75+	<45	45-54	55-64	65-74	75+
C00	Lip	86	47	46.3	52.4	39	34.4	41.3	9	28	27	18	4	85.3	52.9	40.8	26.4	48.2
C01-02	Tongue	988	761	18.1	21.8	227	23.9	26.6	120	269	321	216	62	37.0	25.6	19.3	14.9	28.6
C03-06	Oral cavity	1662	874	30.9	37.0	788	30.1	34.2	216	408	577	353	108	48.4	44.6	31.6	25.4	30.5
C09	Tonsil	250	213	11.2	14.0	37	27.2	31.6	26	67	80	65	12	18.6	16.5	13.0	16.2	48.5
C10	Other oropharynx	158	135	15.9	19.1	23	13.0	15.4	12	44	55	29	18	34.2	18.0	19.9	10.3	14.0
C12-13	Hypopharynx	1017	757	11.9	14.2	260	14.2	15.6	172	259	326	200	60	21.2	17.2	13.2	8.9	4.1
C15	Oesophagus	2016	1229	5.6	7.0	787	9.2	10.5	236	530	689	430	131	11.6	7.1	6.3	10.5	12.0
C16	Stomach	2681	1828	8.3	10.0	853	9.2	10.3	445	635	848	561	192	16.9	12.5	8.3	6.7	2.3
C25	Pancreas	328	231	6.8	7.7	97	10.7	12.2	65	83	95	61	24	12.8	15.3	5.1	5.7	0.0
C32	Larynx	722	651	30.8	37.1	71	30.0	33.6	88	172	262	149	51	64.9	36.4	31.1	33.0	28.1
C33-34	Lung	1806	1527	6.1	7.2	279	8.7	9.7	230	448	654	386	88	16.5	8.8	5.7	4.1	4.7
C50	Breast	3067				3067	43.7	48.6	931	860	696	418	162	58.4	47.0	44.4	37.5	48.4
C53	Cervix	4438				4438	54.0	59.4	1150	1405	1235	515	133	63.4	59.9	55.8	58.0	69.4
C56	Ovary	808				808	27.4	29.7	270	206	195	116	21	49.3	24.4	18.9	11.6	0.0
C67	Urinary bladder	442	318	23.2	30.6	124	23.6	27.9	45	77	111	143	66	41.6	30.5	24.2	35.5	15.1
C81	Hodgkin lymphoma	298	213	36.8	38.5	85	45.5	46.9	228	27	22	14	7	47.0	37.9	12.0	0.0	27.7
C82-85+C96	Non-Hodgkin lymphoma	868	558	20.1	22.1	310	24.5	26.3	418	139	163	117	31	30.6	20.7	20.6	5.0	6.7
C91	Lymphoid leukaemia	433	282	23.1	23.9	151	25.3	25.9	379	8	21	20	5	27.5	0.0	7.2	0.0	0.0
C92-94	Myeloid leukaemia	465	262	14.2	15.4	203	15.3	16.2	279	65	59	52	10	20.9	9.8	8.9	4.6	30.8
C95	Leukaemia unspecified	85	50	10.5	11.1	35	11.2	11.9	51	7	9	13	5	18.6	0.0	12.9	0.0	0.0

Graphs:

5-year absolute survival for male

5-year relative survival for male

5-year absolute survival for female

5-year relative survival for female

5-year relative survival by age group: -45

5-year relative survival by age group: 45-54

5-year relative survival by age group: 55-64

5-year relative survival by age group: 65-74

5-year relative survival by age group: +75

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Chennai, India, 1990-1999)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1984-1989 and 1990-1999 (Chennai, India)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)